UUUU Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Buy now as a momentum-swing entry on weakness. UUUU sold off hard today (-9.81% regular session; 22.11 post-market), but the broader trend still screens bullish (SMA_5 > SMA_20 > SMA_200) and price is sitting near the first key support zone (S1 ~21.59). Options positioning is notably call-heavy (put/call ratios well below 1), suggesting traders are still leaning bullish despite the policy-driven headline selloff. This is a catalyst-driven, sentiment-sensitive name, but the current pullback offers a workable entry for an impatient buyer looking to participate in the uranium/rare-earth upside theme rather than waiting for a perfect setup.
Trend remains bullish on moving averages (SMA_5 > SMA_20 > SMA_200), implying an uptrend despite today’s sharp drawdown. RSI(6) ~45 is neutral, consistent with a reset after the selloff rather than an overbought condition. MACD histogram is still above zero (0.134) but positively contracting, indicating bullish momentum is weakening short-term (typical during pullbacks). Key levels: Pivot ~24.27 is now overhead resistance (regaining it would improve near-term structure); immediate support is S1 ~21.59 (near current post-market 22.11), then S2 ~19.94. Pattern-based odds provided: ~flat next day, weaker next week (-1.05%), but positive next month (+2.22%), aligning with a pullback-then-rebound profile.
Intellectia Proprietary Trading Signals: Intellectia Proprietary Trading Signals
Sector/policy tailwinds still exist around U.S. critical minerals and supply-chain security; prior coverage highlights White Mesa’s strategic position in U.S. uranium/rare-earth processing.
Continued uranium/critical-minerals sentiment remains supportive (even Roth noted rising uranium spot price and sentiment as offsets).
Corporate/strategic actions: Roth referenced an acquisition plan to strengthen rare-earth supply chain positioning.
The 2026-01-29 news highlights a Trump administration policy shift requiring rare-earth projects to demonstrate financial independence, which triggered a sell-off across the space—this is a direct near-term sentiment and funding-risk overhang.
Valuation pushback: Roth (even after upgrading to Neutral) explicitly called valuation “stretched,” and its $15.50 target is well below the current ~$22 area.
High implied volatility indicates the market expects more large swings; headline risk remains elevated.
Latest quarter provided: 2025/Q3. Revenue surged to $17.71M (+337.61% YoY), showing strong top-line growth momentum. However, profitability remains negative: net income was -$16.74M (improved 38.77% YoY but still a loss) and EPS was -$0.07. Gross margin fell to 20.47% (-46.20% YoY), signaling weaker unit economics/mix and reinforcing that execution and scaling (especially in rare earth initiatives) still matter for the equity story.
Recent analyst trend is improving overall with multiple price-target raises and several Buy ratings, but with an important valuation split. Key changes: (1) Roth upgraded from Sell to Neutral on 2026-01-28 and raised PT to $15.50 (still below current price), citing better sentiment/uranium but calling valuation stretched. (2) Canaccord raised PT to C$37 and maintained Buy (2026-01-22). (3) B. Riley raised PT to $27 and kept Buy (2026-01-20), focusing on White Mesa rare-earth refining and supportive U.S. policy. (4) Texas Capital initiated Buy with $20 PT (2025-12-18). Wall Street “pros” view: strategic U.S. asset base (White Mesa), critical minerals theme, upside from execution/offtakes/M&A. “Cons” view: valuation risk and reliance on policy/financing/sentiment-driven catalysts; near-term swings can be dominated by headlines.
